Physician profile
Cheta Nand
NPI 1528163680
$671.25
in general payments reported to CMS, 2019-2025
8 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $12.79 · 2021: $162 · 2022: $86.56 · 2023: $60.60 · 2024: $49.63 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.13 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $337.41 | 2019-2025 | |
| Harmony Biosciences LLC | $171.30 | 2021-2024 | Wakix |
| Sunovion Pharmaceuticals INC. | $69.97 | 2019 | |
| Vanda Pharmaceuticals INC. | $25.19 | 2019 | |
| Axsome Therapeutics, INC. | $22.25 | 2023 | Sunosi |
| Lilly USA, LLC | $20.26 | 2025 | Zepbound |
| Eisai INC. | $12.79 | 2020 | |
| Apria Healthcare LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheta Nand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.